Trials / Completed
CompletedNCT04000204
The Comparison of Two Crosslinked Hyaluronate for the Treatment of Osteoarthritis Pain
The Comparison of Safety and Effectiveness Between HYAJOINT Plus and Bioventus Durolane for the Treatment of Knee Osteoarthritis Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- SciVision Biotech Inc. · Industry
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare the safety and effectiveness between two BDDE-crosslinked hyaluronate, HYAJOINT Plus and Durolane, for the Treatment of Knee Osteoarthritis Pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HYAJOINT Plus | 60 mg / 3 ml cross-linked hyaluronan, SciVision Biotech Inc. |
| DEVICE | Durolane | 60 mg / 3 ml cross-linked hyaluronan, Bioventus LLC. |
Timeline
- Start date
- 2017-06-20
- Primary completion
- 2018-06-15
- Completion
- 2019-07-12
- First posted
- 2019-06-27
- Last updated
- 2020-05-27
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04000204. Inclusion in this directory is not an endorsement.